Research ArticleDrug Discovery and Translational Medicine
Open Access
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain
Walter Kostich, Brian D. Hamman, Yu-Wen Li, Sreenivasulu Naidu, Kumaran Dandapani, Jianlin Feng, Amy Easton, Clotilde Bourin, Kevin Baker, Jason Allen, Katerina Savelieva, Justin V. Louis, Manoj Dokania, Saravanan Elavazhagan, Pradeep Vattikundala, Vivek Sharma, Manish Lal Das, Ganesh Shankar, Anoop Kumar, Vinay K. Holenarsipur, Michael Gulianello, Ted Molski, Jeffrey M. Brown, Martin Lewis, Yanling Huang, Yifeng Lu, Rick Pieschl, Kevin O’Malley, Jonathan Lippy, Amr Nouraldeen, Thomas H. Lanthorn, Guilan Ye, Alan Wilson, Anand Balakrishnan, Rex Denton, James E. Grace, Kimberley A. Lentz, Kenneth S. Santone, Yingzhi Bi, Alan Main, Jon Swaffield, Ken Carson, Sandhya Mandlekar, Reeba K. Vikramadithyan, Susheel J. Nara, Carolyn Dzierba, Joanne Bronson, John E. Macor, Robert Zaczek, Ryan Westphal, Laszlo Kiss, Linda Bristow, Charles M. Conway, Brian Zambrowicz and Charles F. Albright
Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 371-386; DOI: https://doi.org/10.1124/jpet.116.235333
Walter Kostich
Research and Development, Neuroscience Biology (W.K., Y.-W.L., J.F., A.E., C.B., M.G., T.M., J.M.B., M.L., Y.H., Y.L., R.P., R.Z., R.W., L.K., L.B., C.M.C., C.F.A.), Neuroscience Chemistry (C.D., J.B., J.E.M.), Preclinical Candidate Optimization (A.B., J.E.G., K.A.L., K.S.S.), and Discovery Toxicology (R.D.), Bristol-Myers Squibb, Wallingford, Connecticut; Research and Development, Leads Discovery and Optimization, Bristol-Myers Squibb, Pennington, New Jersey (K.O., J.L.); BMS Biocon Research Center, Bangalore, India (K.D., J.V.L., S.N., M.D., S.E., P.V., V.S., M.L.D, G.S., A.K., V.K.H., S.M., R.K.V., S.J.N.); Lexicon Pharmaceuticals, The Woodlands, Texas (B.D.H., K.B., J.A., K.S., A.N., A.W., J.S., B.Z., T.H.L., G.Y.); and Lexicon Pharmaceuticals, Basking Ridge, New Jersey (Y.B., A.M., K.C.)
Brian D. Hamman
Yu-Wen Li
Sreenivasulu Naidu
Kumaran Dandapani
Jianlin Feng
Amy Easton
Clotilde Bourin
Kevin Baker
Jason Allen
Katerina Savelieva
Justin V. Louis
Manoj Dokania
Saravanan Elavazhagan
Pradeep Vattikundala
Vivek Sharma
Manish Lal Das
Ganesh Shankar
Anoop Kumar
Vinay K. Holenarsipur
Michael Gulianello
Ted Molski
Jeffrey M. Brown
Martin Lewis
Yanling Huang
Yifeng Lu
Rick Pieschl
Kevin O’Malley
Jonathan Lippy
Amr Nouraldeen
Thomas H. Lanthorn
Guilan Ye
Alan Wilson
Anand Balakrishnan
Rex Denton
James E. Grace
Kimberley A. Lentz
Kenneth S. Santone
Yingzhi Bi
Alan Main
Jon Swaffield
Ken Carson
Sandhya Mandlekar
Reeba K. Vikramadithyan
Susheel J. Nara
Carolyn Dzierba
Joanne Bronson
John E. Macor
Robert Zaczek
Ryan Westphal
Laszlo Kiss
Linda Bristow
Charles M. Conway
Brian Zambrowicz
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
AAK1, Novel Pain Target
Walter Kostich, Brian D. Hamman, Yu-Wen Li, Sreenivasulu Naidu, Kumaran Dandapani, Jianlin Feng, Amy Easton, Clotilde Bourin, Kevin Baker, Jason Allen, Katerina Savelieva, Justin V. Louis, Manoj Dokania, Saravanan Elavazhagan, Pradeep Vattikundala, Vivek Sharma, Manish Lal Das, Ganesh Shankar, Anoop Kumar, Vinay K. Holenarsipur, Michael Gulianello, Ted Molski, Jeffrey M. Brown, Martin Lewis, Yanling Huang, Yifeng Lu, Rick Pieschl, Kevin O’Malley, Jonathan Lippy, Amr Nouraldeen, Thomas H. Lanthorn, Guilan Ye, Alan Wilson, Anand Balakrishnan, Rex Denton, James E. Grace, Kimberley A. Lentz, Kenneth S. Santone, Yingzhi Bi, Alan Main, Jon Swaffield, Ken Carson, Sandhya Mandlekar, Reeba K. Vikramadithyan, Susheel J. Nara, Carolyn Dzierba, Joanne Bronson, John E. Macor, Robert Zaczek, Ryan Westphal, Laszlo Kiss, Linda Bristow, Charles M. Conway, Brian Zambrowicz and Charles F. Albright
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 371-386; DOI: https://doi.org/10.1124/jpet.116.235333
Research ArticleDrug Discovery and Translational Medicine
AAK1, Novel Pain Target
Walter Kostich, Brian D. Hamman, Yu-Wen Li, Sreenivasulu Naidu, Kumaran Dandapani, Jianlin Feng, Amy Easton, Clotilde Bourin, Kevin Baker, Jason Allen, Katerina Savelieva, Justin V. Louis, Manoj Dokania, Saravanan Elavazhagan, Pradeep Vattikundala, Vivek Sharma, Manish Lal Das, Ganesh Shankar, Anoop Kumar, Vinay K. Holenarsipur, Michael Gulianello, Ted Molski, Jeffrey M. Brown, Martin Lewis, Yanling Huang, Yifeng Lu, Rick Pieschl, Kevin O’Malley, Jonathan Lippy, Amr Nouraldeen, Thomas H. Lanthorn, Guilan Ye, Alan Wilson, Anand Balakrishnan, Rex Denton, James E. Grace, Kimberley A. Lentz, Kenneth S. Santone, Yingzhi Bi, Alan Main, Jon Swaffield, Ken Carson, Sandhya Mandlekar, Reeba K. Vikramadithyan, Susheel J. Nara, Carolyn Dzierba, Joanne Bronson, John E. Macor, Robert Zaczek, Ryan Westphal, Laszlo Kiss, Linda Bristow, Charles M. Conway, Brian Zambrowicz and Charles F. Albright
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 371-386; DOI: https://doi.org/10.1124/jpet.116.235333
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement